Chikungunya virus (CHIKV) has recently affected millions of people in the Indian Ocean, with rare cases of encephalopathy and encephalitis occurring in neonates. In the study described herein, the capacity of mouse brain cells to control infection through innate immune antiviral responses was assessed. In vitro, CHIKV principally infected a subpopulation of mouse GFAP+ primary astrocytes. Oligodendrocytes and neurons could also be infected. An innate immune response was engaged by CHIKV-infected astrocytes with elevated expression of mRNAs for IFN-a"b, inflammatory cytokines (e.g. IL-1b, IL-12, IL-10, IL-24) and proapoptotic factors (e.g. TNF-a, FasL, Lymphotoxin B). Programmed cell death through the intrinsic caspase-9 pathway was observed by immunofluorescence in infected astrocytes and neurons but not in oligodendrocytes. Interestingly, microglia did not replicate CHIKV but responded by elevated mitogen-activated protein kinase (MAPK) activity. Intracerebroventricular injection of CHIKV in neonate mice led to the infection of astrocytes. The astrogliosis response was accompanied by a dendritic CD206+ cell mobilization restricted to the site of infection. The results of this study support the paradigm that a multifaceted innate immune response can be mobilized by both professional immune and glial cells to control CHIKV neuroinfection events in neonates.
INTRODUCTION
Chikungunya virus (CHIKV) is an alphavirus of the Togaviridae family transmitted by mosquitoes of the Aedes genus (Pialoux et al., 2007; Weaver & Barrett, 2004) . The Alphavirus group comprises 29 viruses, six of which can cause severe human joint disorders (arthralgia evolving to arthritis), namely CHIKV, O'nyong-nyong virus (ONNV), Semliki Forest virus (SFV), Ross River virus (RRV), Sindbis virus (SINV) and Mayaro virus (MAYV), while the socalled 'New world alphaviruses' such as eastern equine encephalitis virus (EEEV) and Venezuelan equine encephalitis virus (VEEV) can cause severe brain damage (Griffin, 2003) . Interestingly, CHIKV-associated neuropathology was first described in the 1960s (Carey et al., 1969; Chastel, 1963; Chatterjee et al., 1965; Hammon et al., 1960; Jadhav et al., 1965; Nimmannitya et al., 1969; Thiruvengadam et al., 1965) . However, it is the unprecedented incidence rate in the Indian Ocean with efficient clinical facilities that allowed a better description of rare cases with severe encephalitis, meningoencephalitis, peripheral neuropathies and deaths among newborns (motherto-child infection) (Economopoulou et al., 2009; Gérardin et al., 2008; Hoarau et al., 2010; Ramful et al., 2007; Robin et al., 2008) . Neurological manifestations described in adults requiring hospitalization involved cases of encephalopathy, frequently associated with the presence of IgM anti-CHIKV and infectious virus in the cerebrospinal fluid (CSF), encephalitis, Guillain-Barré, encephalomyeloradiculitis and rare deaths (Chandak et al., 2009; Economopoulou et al., 2009; Ganesan et al., 2008; Lebrun et al., 2009; Lemant et al., 2008; Tournebize et al., 2009; Wielanek et al., 2007) . In a recent histopathological study, it was found that CHIKV infection in adults was associated to bilateral frontoparietal white matter lesions with restricted diffusion, which is described as an early sign of viral encephalitis (Ganesan et al., 2008) . Focal perivascular lymphocytic infiltrates were also present in areas of active demyelination and some degree of microglial activation was noted in the grey matter which may contribute to bystander neuronal loss, as reported experimentally for other alphaviruses (Irani & Prow, 2007) .
Despite limited research in this area to date, the number of cases with central nervous system (CNS) involvement appears to support the neurotropic/neuroinfectious activity of CHIKV. This unique CNS infection illustrated by subventricular white matter lesions and intraparenchymal haemorrhages has previously been described experimentally and in clinical settings for other alphaviruses such as SFV, RRV, EEEV and SINV (Deresiewicz et al., 1997; Fazakerley et al., 2006; Jackson et al., 1987; Mims et al., 1973) .
CHIKV has been shown to infect mouse brain and to replicate in primary culture of glial cells (Chatterjee & Sarkar, 1965; Precious et al., 1974) . Further evidence comes from experimental infections where mice were inoculated subcutaneously, leading to rapid (24 h) and robust replication (10 6 -10 7 p.f.u. ml
21
) of CHIKV in the brain, particularly in newborn outbred mice (CD1, ICR) (Ziegler et al., 2008) . Interestingly, infected mice show signs of illness suggestive of human clinical pathology such as loss of balance, difficulty walking, dragging of hind limbs and skin lesions, but with rare mortality. CNS infection in these mouse models seemed to be tightly controlled by ill-characterized antiviral mechanisms, as the viral titre was reduced to basal levels at day 10 post-infection (p.i.). Intranasal injection of CHIKV injected in BALB/c mice was shown to cause neuronal infection and tissue necrosis in the anterior olfactory lobe (Powers & Logue, 2007) . Weaver and colleagues reported the use of intranasal injection of CHIKV Ross strain in a neuroinvasion model, which was selected due to its excessive mouse passage history and which may have increased its virulence (Wang et al., 2008) . Interestingly, 5-week-old C57BL/6 mice developed encephalitis 7 days p.i., with severe multifocal infection and liquefactive necrosis in the cerebral cortex. Immunohistochemistry techniques revealed that neuron-like cells were infected and induced to apoptosis while prominent microgliosis and perivascular cuffs were distributed throughout the parenchyma. In addition, the authors reported neuronal degeneration in the hippocampus and multifocal lymphocytic leptomeningitis. In inbred mice deficient in the IFN-a signalling pathway, CHIKV neuroinfection was particularly severe and targeted the leptomeninges, the choroid plexus and ependymal cells lining the subventricular zone (SVZ), also known as the neural stem cell niche (Hauwel et al., 2005a, b) . Four additional experimental models (mouse and zebrafish) further confirmed the capacity of CHIKV to infect brain cells following subcutaneous or intraperitoneal injections, causing neuroinflammation and cell death through ill-characterized mechanisms (Dhanwani et al., 2011; Fraisier et al., 2014; Palha et al., 2013; Priya et al., 2014 ).
In the current study, experiments were performed in vitro and in vivo (experimental neuroinfection mouse model) to test for the capacity of CHIKV to infect mouse brain cells and to characterize the subsequent innate immune and apoptosis responses. Observations from this study could potentially shed new light on the pathological mechanisms of the rare CHIKV infection of the CNS, particularly in neonates and elderly patients, and demonstrate to what extent the local innate immune response may control the infectious challenge.
RESULTS

Subset of glial GFAP+ cells and subsequent neurons are infected by CHIKV in vitro
The ability of CHIKV to infect primary cultures of brain cells was investigated to decipher its neuropathogenic potential. In mouse, cells between passage 0 (neurons, oligodendrocytes and microglia) and 1-3 (astrocytes) were incubated at different m.o.i. values (0.1, 1 and 10) of the CHIKV clinical isolate #4. The expression of viral proteins (pE2, E2/E1 and capsid) was detected by immunoblotting of astrocyte cell lysates and by double immunocytochemistry using specific antibodies for CHIKV and different cell markers. Viral E1 gene expression was assessed by real-time (RT)-PCR over the time course of infection. At an m.o.i. of 1, CHIKV was capable of infecting GFAP+ cells and reached 68 ±7.8 % of infected cells at 24 h p.i. (Fig. 1a-e) . Not all astrocytes were infected, as was observed with GFAP+ CHIKV2 cells compared to GFAP+ CHIKV+ cells (Figs 1c, d , f and S1, available in the online Supplementary Material). CHIKV infection of GFAP+ astrocytes was assessed at different m.o.i. over 12, 24 and 48 h p.i., and the immunofluorescence results are depicted in Fig. 1(e) . Type-2 astrocyte cells (GFAP dim and with long and thin processes) were also found to be CHIKV+ (Fig. 1b(ii) , white arrow). Differentiated oligodendrocyte type-2 astrocyte (O2A) progenitors were used to test for the susceptibility of oligodendrocytes to CHIKV infection, and GC+ cells and PLP+ cells were found to stain positive for CHIKV (Figs 1g, h and S1). Nondifferentiated O2A progenitors identified as GC+ bipolar cells (Fig. 1h, inset) were also infected by CHIKV, as indicated by the yellow staining around the nucleus. Mouse microglia cells (C1q+, CD11b/CR3+) were refractory to CHIKV infection and replication, even at an m.o.i. of 10 (Fig. S1 ). The results confirmed that microglia are functionally competent phagocytic cells through their capacity to engulf FITClabelled zymosan particles (Fig. S1 ).
When the kinetics of infection of mouse embryonic brain cultures containing GFAP+ astrocyte cells and b-III tubulin+ (TUJ1) neurons were analysed, CHIKV staining was observed mainly in astrocytes as early as 8-12 h p.i., while neuronal cells growing in clusters were largely spared (Fig. 1i) . At 24 h p.i., CHIKV+ astrocyte cells appeared as apoptotic-like cells and had lost their ramifications (Fig. 1j) . Neuronal infection was evidenced only at 48 h with perinuclear CHIKV staining of TUJ1+ red cells (Figs 1k, l, S1) . At 72 h, TUJ1+ neurons stained for CHIKV displayed multiple vesicles double stained for b-III tubulin and CHIKV (Fig. 1m , white arrow).
Vero cells were used as a positive control of CHIKV infection and viral replication was assessed by analysing E1 gene expression in mouse astrocytes and microglia cultures. We did not obtain sufficiently pure cultures of neurons and oligodendrocytes to confirm viral replication by RTPCR. E1 gene expression was found in CHIKV-infected Vero cells, CLTT astrocyte cells and primary astrocytes (Fig. 2a, b) . In contrast, no signal was detected from primary microglia cell cultures. glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used to control for and validate RNA quality.
CHIKV infection was analysed by Western blotting (WB) of cell lysates from primary mouse astrocytes at different cell culture passages (P). The pE2 and the E1 and E2 envelope proteins were only detected at 24 h p.i. in CHIKV-infected cells (P1 up to P3), in contrast to mock-infected (control) cells (Fig. 2c) . By WB analysis, CHIKV (m.o.i.51, 24 h) was found to equally infect several mouse cell lines (NIE115 neuroblastoma, STO and 3T3L1 fibroblasts, C2C12 myoblasts, Bend3 endothelial cells); however, B16 melanoma and BV2 microglia were not infected (Fig. 2d) .
Innate immune responses in astrocytes infected by CHIKV
Astrocytes play a critical role in host defence mechanisms of the immunoprivileged brain (Farina et al., 2007) and alphaviruses such as SINV are known to instigate a robust innate immune responses in the CNS (Ryman & Klimstra, 2008) . Therefore, the effect of CHIKV infection on the innate immune function of astrocytes was investigated. Quantitative RT-PCR was performed by superarray technology of primary astrocytes in response to CHIKV infection (m.o.i.51) over a time course of 2-48 h. Of note, it was observed that 23 ±12 % of the cells were dead at 48 h p.i. using trypan blue staining, therefore the gene profiling data were considered only at 24 h p.i. with less than 5 % dead (necrotic) cells. 9 viral RNA copies/10 6 astrocyte cells ml 21 of tissue culture supernatants (TCS) were detected. This expression was significantly lower at an m.o.i. of 0.1 with 9.91 ±2.69 6 10 8 viral RNA copies/10 6 astrocyte cells ml 21 of TCS. Using superarray gene profiling experiments, several inflammatory and growth factor genes were observed to be significantly upregulated following CHIKV infection. Expression of IFN-a2/a4/b were highly upregulated at 24 h p.i. in CHIKV-infected when compared with control cells (Table  1 ). FasL and TNF-a, known to be involved in apoptosis, were also significantly upregulated in response to infection.
Rapid mobilization of apoptosis in astrocytes and neurons infected by CHIKV
The cytopathic activity of CHIKV on neurons and astrocytes was characterized by TUNEL and immunocytochemistry to screen for surrogate markers of apoptosis. The results demonstrate that 71 ±23 % of the astrocytes exposed to CHIKV for 24 h stained for DNA fragmentation in the nuclei (TUNEL+ nuclei) (Fig. 3) . Apoptotic neurons were also detected particularly at 48 h p.i., while oligodendrocytes failed to display TUNEL+ nuclei (Fig. 3) . To establish the early (24 h) and late (48-72 h) molecular mechanisms of cell death, mitochondrial events (cytochrome c), cleaved caspase-9, and cleaved PARP were tested in mock-and CHIKV-infected primary astrocytes. When astrocyte cells were exposed to CHIKV, a cytoplasmic distribution of the cytochrome c staining was observed at 24 h p.i. (Fig. 4b) . In contrast, a granular/punctate staining pattern due to the natural mitochondrial localization of cytochrome c was detected in mock-infected control cells (Fig. 4a) . Interestingly, cytochrome c distribution in the cytoplasm of apoptotic cells was identified in CHIKV+ as well as in CHIKV2 cells, suggesting bystander apoptosis mechanisms (Fig. 4b) . Cleaved PARP and cleaved caspase-9 were detected in CHIKV+ cells at 24 h. At 48-72 h p.i., many CHIKV+ cells presented strongly cleaved PARP staining (Fig. 4e, f) . Fig. 4 (g) clearly depicts that cells stained for cleaved caspase-9 were astrocytes stained for glial fibrillary acidic protein (GFAP).
Microglia are activated in response to CHIKV
As shown in Fig. 5 (a, b), microglia (arrow) were not infected by CHIKV and no cell necrosis or cell blebbing were detected following infection at an m.o.i. of 1 at 24 h p.i. This was in sharp contrast to mouse astrocytes displaying bleb-like structures in response to CHIKV (arrowhead, Fig. 5a (iv), b). Bright-field observations were confirmed by double immunofluorescence studies (Fig. 5c ), confirming that CD45+ microglia failed to stain for CHIKV. However, examinations at higher magnifications of the CD45 staining, indicated that CHIKV-exposed microglia were (Fig. 5e ). To test for microglia activation, staining for phospho-mitogen-activated protein kinase (MAPK p44/ 42) was performed and a more robust staining in CHIKVexposed microglia cultures compared with mock-infected control cells was observed [ Fig. 5f (iii), (iv)]. In addition, the staining was associated to the nuclear membrane, possibly as a consequence of the translocation of the activated protein.
Less than 2 % of mock-infected microglia displayed a nuclear MAPK p44/42 staining compared with 55 ±28 % in CHIKV-infected microglia (m.o.i. 5 1, 24 h) (P,0.05). Astrocyte-like cells did not display nuclear MAPK p44/42 staining in response to CHIKV [ Fig. 5f(iv) , g].
CHIKV targets astrocytes in the CNS leading to rapid mobilization of dendritic cells
OF1 newborn mice and the intracerebroventricular (ICV) injection route were used to address the capacity of CHIKV to infect brain cells in situ. Two independent experiments were performed with four CHIKV-injected animals compared to four PBS-injected controls. At 24 h p.i., the large majority of CHIKV staining was associated with cells also stained for GFAP, a marker of astrocytes (Fig. 6a) . The infection was confirmed in all eight infected neonate mice, and was consistently localized and limited to the site of injection, while the choroid plexus (Cpx) did not stain for CHIKV. A marked astrogliosis (strong GFAP staining) was noted in the ipsilateral side. Remarkably, a robust mobilization of CD206+ dendritic cells was identified facing the infectious site (Fig. 6c) . CD206 dendritic cells could not be detected in the contralateral site (data not shown). A low number of CD45+ (leukocytes) cells were recruited and scattered in the contralateral site while no staining for CHIKV was detected (Fig. 6b, d ).
DISCUSSION
Viruses are the most abundant pathogens that the host innate immune system is challenged by, particularly when they find a privileged niche inside the CNS tissue (Griffin, 2003) . Alphaviruses, like many other RNA viruses, are known to infect the CNS and to induce neuronal cell injury, yet our understanding of the mechanisms involved in CHIKV neuropathology is still in its infancy (Fazakerley et al., 1983; Griffin, 2003) . In most tissues, the loss of infected cells preferably by apoptosis is essential to ward off the infectious challenge and this beneficial phase is rapidly 
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accompanied by enhanced cell division to replenish the cell population. The balance would be to favour non-cytolytic clearance of the virus to preserve neuronal connections, even if this could promote latent viral infection (Binder & Griffin, 2001) . Although CHIKV was shown to infect the brain in neonates and elderly patients, which has been confirmed in several mouse and zebrafish models, this is the first study reporting the identity of the target cells and the nature of the innate immune and antiviral responses to control the infectious challenge in vitro and in vivo.
Webb and colleagues were the first to report CHIKV infection of brain glial cells in 1974, however, the cell type involved was not addressed (Precious et al., 1974) . In the current study, astrocytes and oligodendrocytes were found to be highly susceptible to CHIKV infection. Astrocytes were stained for CHIKV and viral replication was detected by RT-PCR as early as 8-12 h p.i. CHIKV-infected astrocytes rapidly died at 48 h p.i. Not all GFAP+ cells were found to be equally infected, even at later time points, suggesting that a subset of astrocytes did not express the receptor to assist CHIKV entry and/or were able to mount a robust antiviral response to control the infection. These cells could potentially be sorted on the basis of their CHIKV staining and gene profiling subsequently performed to (ii) (i) ascertain the exclusive molecular signatures of the resistant astrocyte subsets compared to the susceptible cells.
CHIKV was also able to infect O2A progenitors and oligodendrocytes; however, in contrast to SFV (Glasgow et al., 1997) , it did not cause apoptosis as indicated by the TUNEL assay. It is possible that oligodendrocytes can mobilize different anti-apoptotic factors as shown for neurons, particularly Bcl2 (Kerr et al., 2002) .
Mouse microglial cells were highly resistant to infection and failed to replicate CHIKV. In contrast, microglial cells exposed to CHIKV and/or possibly to cell debris released from surrounding CHIKV+ astrocytes, displayed a more amoeboid-like shape with many large intracytoplasmic vesicles. This unique microglia morphology bears a resemblance to the ballooned macrophages detected in human synovial biopsy chronically infected by CHIKV (Hoarau et al., 2010) . The mobilization of the p44/42 MAPK pathway by mouse microglia is interesting, and it is possible that CHIKV (or a factor released from infected astrocytes) can modulate their cellular activity. This is in agreement with previous data showing the activation of microglia exposed to SFV alphavirus (McKimmie & Fazakerley, 2005; McKimmie et al., 2006) and SINV (Esen et al., 2012) . Microglia express several pattern recognition receptors involved in virus sensing and can be induced to express high levels of IL-12, IFNa and TNF-a in response, for example, to neuroadapted SINV (Esen et al., 2012) . However, a human microglial cell line (CHME) was recently shown to support CHIKV replication, in sharp contrast to the results from the current study using primary cultures and the mouse BV2 cell line (Wikan et al., 2012) . CHME has been obtained through immortalization procedures using a virus, which may have induced the selection of a clone capable of supporting CHIKV infection.
Embryonic neurons were also infected by CHIKV but, surprisingly, at a much later time point (48 h). At 72 h p.i., neurons were shedding multiple membrane-bound microvesicles stained for CHIKV, which may correspond to apoptotic blebs (Krejbich-Trotot et al., 2011) . The identity of the receptor for CHIKV is unknown and its expression may be differentially modulated on neurons.
This study provides novel data supporting the paradigm that CHIKV can infect brain cells and could directly alter cell functions in terms of tissue homeostasis (astrocytes) and neuronal function. In two studies, it was found that CHIKV replicated at high levels in brain tissues, contributing to neuronal injuries and associated with gliosis (Wang et al., 2008; Ziegler et al., 2008) . The results from the current study are in agreement with these observations.
CHIKV was shown to have profound cytopathic effects in vivo and in vitro on human cells (Couderc et al., 2008; Ozden et al., 2007; Sourisseau et al., 2007) ; there is a rapid shut-off of host cell transcription and translation followed by apoptotic death as assessed by the presence of numerous active caspase-3 and CHIKV double-positive cells (Sourisseau et al., 2007) . These data were obtained using the HeLa epithelial cell model and results are unknown for neuronal and glial cells. The results clearly indicate that CHIKV was extremely efficient at inducing apoptosis (TUNEL+) in astrocytes (GFAP+ cells) and neurons. The data further showed that the intrinsic apoptosis pathway (mitochondrial, caspase-9) was mobilized consequently to CHIKV infection in astrocytes. The contribution of the extrinsic pathway cannot be excluded at this stage given that several death ligands (FasL, CD40L, TNF-a) were upregulated in CHIKV-infected astrocytes, which are involved in FADD death receptormediated pathway.
In conclusion, the robust innate immune response, the profound apoptosis and the inflammatory cascade Multifaceted anti-Chikungunya immunity by brain cells production of more proinflammatory compared to antiinflammatory molecules may exert detrimental effects.
METHODS
Cells, culture conditions and CHIKV infection. Vero cells (African green monkey kidney epithelial cells) and CLTT mouse astrocyte cells were used to grow CHIKV (Galiana et al., 1990; Griffiths et al., 2009) . CHIKV infection was also tested in several control mouse cell lines: B16 (melanoma cell line), BV2 (microglia cell line), NIE115 (neuronal cell line), STO (embryonic fibroblast cell line), bEnd.3 (brain endothelial cell line), C2C12 (myoblast cell line) and 3T3L1 (embryonic fibroblastadipose like cell line). CD12 newborn (1-2 days old) mouse embryos (E16-18) were used for primary glial and neuronal cultures, respectively. All cultures were prepared as described by Rogers et al. (1996) . In brief, brain tissues were dissociated with trypsin/DNase I (Dutscher) and cultured on poly-L-Lysine (PLL) coated flasks. Mouse model of CHIKV neuroinfection. Outbred OF1 mice were used according to the CYclotron Réunion Océan Indien (CYROI) institution guidelines for animal husbandries and experiments (French's state authorization 2009/0126 and personal experiment authorization reference A82122007001). Newborns and mother were kept in air filtered isolators contained in a BSL3 laboratory for at least 2 days before manipulation. Two-to 3-day-old mice were inoculated by intracerebroventricular (ICV) injection (right anterior site from the bregma) with 10 ml viral suspension diluted with Dulbecco's modified Eagle's medium (equivalent of 10 4 p.f.u. of CHIKV). Mockinfected mice received medium alone. Four mice were tested in each experimental condition and the experiment was repeated twice. The principles of good laboratory animal care were followed through the experimental process. Animals were monitored regularly and sacrificed at day 1 or day 2 p.i. to collect brain samples. Tissues were stored in 4 % paraformaldehyde (24-48 h) before being processed for cryosectioning and immunofluorescence studies.
Immunofluorescence staining. Adherent cells were grown and infected on glass coverslips, then fixed and permeabilized with cold 90 % ethanol for 5 min. Cells were incubated in primary antibodies (1/200) in PBS BSA 1 % and then incubated with secondary antibodies. Nucleus morphology was revealed by addition of DAPI (Sigma; final concentration 100 ng ml 21 ). Coverslips were mounted in vectashield solution and fluorescence was observed under a Nikon Eclipse E2000 U microscope, magnification 6400. Images were obtained using the Nikon Digital sight PS-U1 camera system and the imaging software NIS-Element AR (v2.3).
Primary antibodies listed below were used to stain for specific cell markers and to detect CHIKV-infected cells and associated cytopathic activities. Human antisera against CHIKV (FDO) and two mouse mAbs (clones 6C and 4F, a kind gift from bioMérieux and the Armed Forces Institute of Tropical Medicine) were used to detect CHIKV. Mouse monoclonal anti-alphavirus (recognizing a common epitope in the capsid protein of several alphaviruses) was from Santa Cruz. Polyclonal rabbit anti-mouse GFAP (Sigma) was used to stain astrocytes, which could be enriched at 95-99 %. Mouse anti-CNPase (MAB326), mouse anti-GC (MAB342) and mouse anti-PLP (MAB388) were from Millipore and used to stain oligodendrocytes and O2A progenitors. Microglia enriched at 90-95 % were stained for CD11b/complement receptor type III, using the hybridoma clone M1/ 70.15.11.5.2. rat IgG2a anti-mouse (Developmental studies hybridoma bank, University of Iowa) or with the rabbit polyclonal anticomplement C1q (Dako). Mouse anti-human CD18 (Serotec) was used to stain human microglia.
Rat anti-mouse CD206 (dendritic cell marker) and anti-mouse CD45 (macrophage/microglia marker) were both from Serotec. Embryonic neurons were identified as b-III tubulin+ cells using the TUJ1 mAb (RnD Systems) but could not be totally dissociated from the astrocyte layer.
Rabbit anti-mouse cytochrome c, cleaved PARP and cleaved caspase-9 were all from Cell Signalling. Secondary antibodies were goat antirabbit or anti-mouse conjugated to Alexa Fluor 488, goat anti-rabbit or anti-mouse conjugated to Alexa Fluor 594 and goat anti-human Alexa Fluor 488 (Invitrogen Molecular Probes). Rabbit anti-phospho p44/42 MAPK to detect microglia activation was from Cell Signalling.
WB analysis. Cell pellets (10 7 cells) were resuspended in lysis buffer [PBS 1X, Triton X-100 1 %, EDTA 1 mM, plus a protease inhibitor cocktail (PMSF, pepstatinA, leupeptin, aprotinin) ]. Approximately 50 mg of each sample was loaded onto a 4-12 % NuPAGE gel from Invitrogen. After the electrophoretic migration, proteins were electrotransferred onto a nitrocellulose membrane (GE Healthcare Life Sciences). Membranes were incubated overnight with anti-CHIK (FDO). Membranes were incubated with HRP-conjugated secondary antibodies: goat anti-rabbit or anti-human IgG (H+L) HRPconjugated (Bio-Rad), goat anti-human IgG (Fc specific) HRPconjugated (Sigma).
RT-PCR and qRT-PCR. Total RNA was extracted directly from various cells or cell culture supernatant using Trizol Reagent (Invitrogen). One-step RT-PCR and qRT-PCR for E1 CHIKV were performed as described previously (Hoarau et al., 2010) . Primers for the CHIKV E1 gene (EU-037962.1) were: AAG CTY CGC GTC CTT TAC CAA G (F) and CCA AAT TGT CCY GGT CTT CCT (R). Primers for GAPDH (NM 002046) were: GAA CGG GAA GCT TGT CAT CA (F) and TGA CCT TGC CCA CAG CCT TG (R). Two RT 2 Profiler TM PCR arrays, mouse inflammatory cytokines and receptors kit (PAMM-021A) and mouse apoptosis kit (PAMM-012A) from SAS Biosciences were used to perform gene profiling. Details of the arrays can be obtained from the following websites: http://www. sabiosciences.com/genetable.php?pcatn=PAMM-021A and http://www. sabiosciences.com/genetable.php?pcatn=PAMM-012A. The fold-change versus control for each gene was calculated with the DDCt method using the RT 2 Profiler PCR Array Data Analysis Template v3.0 (SuperArray, Bioscience Corporation). Briefly, DDCt5DCt (CHIKV) 2 DCt (control) with DCt 5 average Ct 2 average of housekeeping genes' Ct (GAPDH, actin). The fold-change for each gene between the patient and the control is calculated as 2
2DDCt
. Results are included in Table 1 .
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Statistical analysis. Gene expression levels were expressed as mean±SD. Comparisons were analysed by Student's t-test, and values of P,0.05 were considered statistically significant. Statistical tests were performed using GraphPad PRISM V5.
